Eric R. Olson
Eric R. Olson occupies the position of Chief Scientific Officer for Syros Pharmaceuticals, Inc. He is also on the board of Cystic Fibrosis Foundation and National Brain Tumor Society, Inc.
In the past he occupied the position of Vice President-Research at Vertex Pharmaceuticals, Inc., Research Scientist at The Upjohn Co. and Director-Antibacterials & Molecular Sciences at Warner-Lambert Co.
Dr. Olson received an undergraduate degree from the University of Minnesota and a doctorate from the University of Michigan.
|04/01/2022||27,266||Derivative/Non-derivative trans. at $1.12 per share.||30,538|
|01/05/2022||2,208||Disposition at $3.47 per share.||7,662|
|07/01/2021||1,164||Disposition at $5.55 per share.||6,461|
|03/15/2021||3,628||Disposition at $9.47 per share.||34,358|
|03/15/2021||3,628||Derivative/Non-derivative trans. at $1.01 per share.||3,664|
|08/18/2020||10,787||Disposition at $13 per share.||140,231|
|08/18/2020||10,787||Derivative/Non-derivative trans. at $1.01 per share.||10,894|
|08/17/2020||4,963||Disposition at $13 per share.||64,519|
|08/17/2020||4,963||Derivative/Non-derivative trans. at $1.01 per share.||5,012|
|07/07/2020||1,753||Disposition at $11.72 per share.||20,546|
|02/18/2020||1,446||Disposition at $7.38 per share.||10,672|
|02/12/2019||87,000||Award at $0 per share.||0|